The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit ...

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...

CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

CVS Health ( NYSE: CVS) subsidiary Oak Street Health has reached a $60M settlement with the Department of Justice to resolve ...

The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...